Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.36

+1.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David L. Hachey who wrote (15798)	2/25/1998 11:24:00 AM
From: Peter Singleton	Read Replies (2) of 32384

Dave, thanks for your response. So, what you're saying is suppose LGND releases Targretin (tm) for cancer, and Lilly releases T-retin (tm) for diabetes ... identical product, different packaging, that oncologists will prescribe Targretin, but not T-retin, and endocrinologists will do the reverse. My thought was how do LGND and LLY trace whether the product they sell is going into the indications they have the primary marketing rights for ... and it seems like you're saying physicians prescribing behavior + separate packaging will take care of this. I'd be interested in hearing from anyone who's had experience with one of these deals ... but what you said makes sense to me. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next